fda compounding semaglutide crackdown news today 2025 New project announcement: HHS‑OIG is taking a closer look at FDA's oversight of compounded GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these drugs at scale. Our 🚨 FDA Moves to Permanently

This serves as a cautionary note that apparent axonal contacts at low magnification may be deceiving, and that enhanced microscopy may be needed to reveal true contacts

No clinically significant QTc prolongation has been observed with orforglipron in thorough QT studies or clinical trial ECG monitoring

GLP-1 medications like semaglutide and tirzepatide have helped millions lose weight by slowing stomach emptying and reducing hunger signals in the brain

Ive lost 10 lbs already! Love the Annapolis Team

Minimizing Risk for Diabetic Retinopathy Nursing management plays a vital role in implementing individual care plans and educating patients

The deficit that existed at week four may be considerably smaller by week sixteen